Keyphrases
Direct Interaction
100%
Methotrexate
100%
High Mobility Group Box 1 (HMGB1)
100%
Binding Protein
12%
Binding Region
12%
Anti-inflammatory Activity
12%
Anti-inflammatory Effect
12%
T7 Phage Display
12%
Autoimmune Disease
6%
Mechanism of Action
6%
Chemotherapy
6%
Rheumatoid Arthritis
6%
Genetic Engineering
6%
Binding Site
6%
Electrophoretic Mobility Shift Assay
6%
Cellular Level
6%
Mode of Action
6%
Dissociation Constant
6%
Binding Affinity
6%
Direct Binding
6%
Methylenetetrahydrofolate Reductase (MTHFR)
6%
Macrophage-like
6%
Mitogenic Activity
6%
Antitumor Effect
6%
RAW264.7
6%
Truncated Version
6%
Surface Plasmon Resonance Analysis
6%
Released-activity
6%
Tumor Disease
6%
Display Screen
6%
T7 Phage
6%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
High Mobility Group B1 Protein
100%
Enterobacteria Phage T7
20%
Binding Protein
13%
Neoplasm
13%
Anti-Inflammatory Drug
13%
Antiinflammatory Activity
13%
Autoimmune Disease
6%
Chemotherapy
6%
Electrophoretic Mobility Shift Assay
6%
Tumor Necrosis Factor
6%
Binding Site
6%
Rheumatoid Arthritis
6%
Dihydrofolate Reductase
6%
Surface Plasmon Resonance
6%
2 Amino 2 Methyl 3 (2 Trifluoromethyl 5 Benzimidazolyl)propionic Acid
6%
Methotrexate Derivative
6%
Inflammatory Arthritis
6%
Immunology and Microbiology
Methotrexate
100%
Antiinflammatory Activity
25%
Enterobacteria Phage T7
18%
Protein Binding
12%
Phage Display
12%
Binding Affinity
6%
Macrophage
6%
Tumor Necrosis Factor
6%
Autoimmune Disease
6%
Gel Mobility Shift Assay
6%
Binding Site
6%
Inflammatory Arthritis
6%
Mitogenesis
6%
Dissociation Constant
6%
Surface Plasmon Resonance
6%
High Mobility Group Box Domain
6%
Biochemistry, Genetics and Molecular Biology